Share This Page
Drug Price Trends for SM CHILD COLD-ALLERGY LIQUID
✉ Email this page to a colleague
Average Pharmacy Cost for SM CHILD COLD-ALLERGY LIQUID
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SM CHILD COLD-ALLERGY LIQUID | 70677-0101-01 | 0.02240 | ML | 2024-12-18 |
| SM CHILD COLD-ALLERGY LIQUID | 70677-0101-01 | 0.02277 | ML | 2024-11-20 |
| SM CHILD COLD-ALLERGY LIQUID | 70677-0101-01 | 0.02247 | ML | 2024-10-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for SM CHILD COLD-ALLERGY LIQUID
Market Overview
The market for over-the-counter (OTC) cough, cold, and allergy medicines is experiencing significant growth, driven by several key factors. Here’s a detailed analysis of the market and price projections for SM CHILD COLD-ALLERGY LIQUID.
Market Drivers
Accessibility and Affordability
The OTC cough, cold, and allergy medicine market is bolstered by the accessibility and affordability of these products. With over 54,000 pharmacies and more than 750,000 retail outlets in the U.S. alone, these medicines are widely available[3].
Shift from Prescription to OTC
There is a notable trend of manufacturers switching their products from prescription (Rx) to OTC. This shift increases the availability of these drugs and contributes to market growth[3].
Increasing Demand for Self-Medication
The modern consumer's preference for self-medication due to busy lifestyles and the rising number of immunocompromised individuals are driving the demand for OTC cough, cold, and allergy medicines[3].
Market Size and Growth
The global child cold medicine market, which includes products like SM CHILD COLD-ALLERGY LIQUID, is projected to grow at a CAGR of 5.4% through 2030. The market was valued at USD 17.49 billion in 2023 and is expected to reach USD 25.27 billion by 2030[4].
Price Trends
Current Pricing
The average pharmacy cost for SM CHILD COLD-ALLERGY LIQUID has been relatively stable, with prices ranging from $0.02240 to $0.02305 per milliliter over the past year[2].
Price Projections
Given the stable pricing trend and the overall market growth, it is likely that the price of SM CHILD COLD-ALLERGY LIQUID will remain competitive. However, slight fluctuations can be expected due to factors such as raw material costs, manufacturing expenses, and market competition.
Regulatory Considerations
Safety and Age Restrictions
The use of cough and cold products in children is heavily regulated due to safety concerns. For instance, the FDA has issued advisories recommending that OTC cough and cold products not be used in children under 2 years old, and manufacturers have voluntarily modified their labels to reflect these warnings[1].
Impact on Pricing
Regulatory changes and safety warnings can influence consumer behavior and demand, which may have indirect effects on pricing. However, these regulations are more likely to impact the formulation and labeling of products rather than their prices directly.
Competitive Landscape
Product Differentiation
Products like SM CHILD COLD-ALLERGY LIQUID compete in a crowded market where differentiation is key. Formulations that are alcohol-free and specifically designed for children, such as Dimetapp Cold & Allergy, are popular choices[5].
Private Label Products
The rise of private label OTC products also affects the competitive landscape. These products often offer similar efficacy at lower prices, which can pressure branded products to maintain competitive pricing[3].
Distribution Channels
Retail and Online Sales
The expansion of distribution channels, including e-commerce platforms, has made OTC cough, cold, and allergy medicines more accessible. This increased accessibility is expected to drive sales and maintain competitive pricing[4].
Consumer Awareness and Preferences
Natural and Safe Options
There is a growing preference among consumers for natural and safe options for child healthcare. This trend can influence the demand for certain products and may lead to innovations in formulations that are perceived as safer and more natural[4].
Key Takeaways
- The OTC cough, cold, and allergy medicine market is growing at a CAGR of 5.4% through 2030.
- SM CHILD COLD-ALLERGY LIQUID is part of a market valued at USD 17.49 billion in 2023, expected to reach USD 25.27 billion by 2030.
- Prices are expected to remain competitive, with slight fluctuations possible due to market and regulatory factors.
- Regulatory safety warnings and consumer preferences for safe and natural options will continue to shape the market.
FAQs
1. What is the projected growth rate of the child cold medicine market?
The child cold medicine market is projected to grow at a CAGR of 5.4% through 2030[4].
2. What are the key drivers of the OTC cough, cold, and allergy medicine market?
Key drivers include accessibility, affordability, the shift from prescription to OTC, and increasing demand for self-medication[3].
3. What are the safety considerations for using SM CHILD COLD-ALLERGY LIQUID in children?
OTC cough and cold products, including SM CHILD COLD-ALLERGY LIQUID, should not be used in children under 2 years old due to the risk of serious adverse reactions[1].
4. How does the competitive landscape affect the pricing of SM CHILD COLD-ALLERGY LIQUID?
The competitive landscape, including private label products and consumer preferences, pressures branded products to maintain competitive pricing[3].
5. What role do distribution channels play in the market for SM CHILD COLD-ALLERGY LIQUID?
The expansion of distribution channels, including e-commerce platforms, makes these products more accessible and drives sales[4].
Cited Sources:
- Cough and Cold Therapeutic Class Review (TCR) - Texas Health and Human Services.
- Drug prices and trends for CHILD COLD-ALLERGY LIQUID - DrugPatentWatch.
- OTC Cough, Cold & Allergy Medicine Market 2032 - Fact.MR.
- Child Cold Medicine Market: Global Industry Analysis - Maximize Market Research.
- Children's Dimetapp® Cold & Allergy Medicine - Dimetapp.
More… ↓
